← Back to Patent Explorer
US4976969A Expired / Lapsed US ⏱️ 0.0 years remaining

Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex

Assignee: Rohm and Haas Co
•
Filing: 1988-11-09
•
Granted: 1990-12-11
•
Expires: 2008-11-09
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An ophthalmic solution comprising 0.1 to 0.9 % volume of povidone iodine in association with a suitable ophthalmic carrier. The solution is useful in treating various ophthalmic disorders such as follicular conjunctivitis and giant papillary conjunctivitis resulting from reaction to contact lenses, cosmetics and allergies among others. It is also useful in the treatment of ocular dryness resulting from post menopausal stage and from Sjogren's disease.

Inventors

  • 👤 Marc Plamondon

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 17:11
CPC Classifications
A; A61; A61K; A61K33/00; A61K33/18; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/58; A61K9/00; A61K9/0012; A61K9/0048

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 57 words
A method for treating allergic follicular conjunctivitis, giant papillary conjunctivitis, vernal conjunctivitis, kerato conjunctivitis sicca, and ocular dryness, which comprises administering a therapeutically effective amount of an ophtalmic solution which comprises about 0.4 to 0.9% of povidone iodine in association with a pharmaceutically acceptable ophtalmic carrier selected from the group consisting of hydroxyethyl cellulose, methylcellulose and polyvinylalcohol.
Claim 2
Independent Claim 57 words
A method for treating allergic follicular conjunctivitis, giant papillary conjunctivitis, vernal conjunctivitis, kerato conjunctivitis sicca, and ocular dryness, which comprises administering a therapeutically effective amount of an ophtalmic solution which comprises about 0.4 to 0.9% of povidone iodine in association with a pharmaceutically acceptable ophtalmic carrier selected from the group consisting of hydroxyethyl cellulose, methylcellulose and polyvinylalcohol.

References Cited (Backward Citations)

US3911107A Cited
US4031209A Cited
US4364929A Cited
US4401651A Cited
US4452780A Cited
US4525346A Cited
US4581226A Cited
US4713446A Cited
US4851513A Cited
US4708873A Cited
US4873265A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-12-10 1994-06-11 1994-12-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-12-10 1998-06-11 1998-12-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-12-10 2002-06-11 2002-12-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag